W N Hait

2.8k total citations · 1 hit paper
40 papers, 2.3k citations indexed

About

W N Hait is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, W N Hait has authored 40 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 12 papers in Organic Chemistry and 11 papers in Oncology. Recurrent topics in W N Hait's work include Cancer therapeutics and mechanisms (8 papers), Phenothiazines and Benzothiazines Synthesis and Activities (5 papers) and Estrogen and related hormone effects (5 papers). W N Hait is often cited by papers focused on Cancer therapeutics and mechanisms (8 papers), Phenothiazines and Benzothiazines Synthesis and Activities (5 papers) and Estrogen and related hormone effects (5 papers). W N Hait collaborates with scholars based in United States. W N Hait's co-authors include James M. Ford, Walter C. Prozialeck, John S. Lazo, Benjamin Weiss, Jin Yang, Michael D. Ward, T. G. Parmer, Jian‐Ming Yang, Elizabeth Alli and Ed Cadman and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

W N Hait

39 papers receiving 2.3k citations

Hit Papers

Pharmacology of drugs that alter multidrug resistance in ... 1990 2026 2002 2014 1990 250 500 750

Peers

W N Hait
Markos Leggas United States
H. Grunicke Austria
Alan J. Townsend United States
Erasmus Schneider United States
W N Hait
Citations per year, relative to W N Hait W N Hait (= 1×) peers Shin‐ichi Akiyama

Countries citing papers authored by W N Hait

Since Specialization
Citations

This map shows the geographic impact of W N Hait's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W N Hait with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W N Hait more than expected).

Fields of papers citing papers by W N Hait

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W N Hait. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W N Hait. The network helps show where W N Hait may publish in the future.

Co-authorship network of co-authors of W N Hait

This figure shows the co-authorship network connecting the top 25 collaborators of W N Hait. A scholar is included among the top collaborators of W N Hait based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W N Hait. W N Hait is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alli, Elizabeth, Jian‐Ming Yang, & W N Hait. (2006). Silencing of stathmin induces tumor-suppressor function in breast cancer cell lines harboring mutant p53. Oncogene. 26(7). 1003–1012. 87 indexed citations
2.
Hait, W N. (2001). The prognostic and predictive values of ECD-HER-2.. PubMed. 7(9). 2601–4. 10 indexed citations
3.
Yang, Jin, Marie A. Iannone, Weichung Joe Shih, Yong Lin, & W N Hait. (2001). Disruption of the EF-2 kinase/Hsp90 protein complex: a possible mechanism to inhibit glioblastoma by geldanamycin.. PubMed. 61(10). 4010–6. 60 indexed citations
4.
DiPaola, Robert S., Parvesh Kumar, W N Hait, & Robert E. Weiss. (2001). State-of-the-art prostate cancer treatment and research. A report from the Cancer Institute of New Jersey.. PubMed. 98(2). 23–33. 7 indexed citations
5.
Parmer, T. G., et al.. (1998). Activity and regulation by growth factors of calmodulin-dependent protein kinase III (elongation factor 2-kinase) in human breast cancer. British Journal of Cancer. 79(1). 59–64. 74 indexed citations
6.
August, David A., Robert S. DiPaola, Therese Kearney, & W N Hait. (1996). Model of comprehensive diagnosis and care for breast cancer patients.. PubMed. 93(5). 27–34. 1 indexed citations
7.
Yang, Jinming, Khew‐Voon Chin, & W N Hait. (1995). Involvement of Phospholipase C in Heat-Shock-Induced Phosphorylation of P-Glycoprotein in Multidrug Resistant Human Breast Cancer Cells. Biochemical and Biophysical Research Communications. 210(1). 21–30. 18 indexed citations
8.
Hait, W N, Joan Gesmonde, & E. Cheng. (1995). Effects of KS-501, KS-502 and their enantiomers on calmodulin-sensitive enzyme activity and cellular proliferation. Biochemical Pharmacology. 50(1). 69–74. 5 indexed citations
9.
Halperin, Edward C., S. Clifford Schold, Nicholas A. Vick, et al.. (1994). A phase III randomized prospective trial of external beam radiotherapy (ERT), mitomycin C (MITO), BCNU, and 6-mercaptopurine (6-MP) for the treatment of adults with anaplastic glioma of the brain. International Journal of Radiation Oncology*Biology*Physics. 30. 214–214. 1 indexed citations
10.
Hait, W N, Susobhan Choudhury, S. Srimatkandada, & John R. Murren. (1993). Sensitivity of K562 human chronic myelogenous leukemia blast cells transfected with a human multidrug resistance cDNA to cytotoxic drugs and differentiating agents.. Journal of Clinical Investigation. 91(5). 2207–2215. 31 indexed citations
11.
Aftab, Dana T., Lawrence M. Ballas, Carson R. Loomis, & W N Hait. (1991). Structure-Activity Relationships of Phenothiazines and Related Drugs for Inhibition of Protein Kinase C. Molecular Pharmacology. 40(5). 798–805. 27 indexed citations
12.
13.
Ford, James M., W N Hait, Stephen A. Matlin, & Christopher C. Benz. (1991). Modulation of resistance to alkylating agents in cancer cell by gossypol enantiomers. Cancer Letters. 56(1). 85–94. 30 indexed citations
14.
Benz, Christopher C., Max A. Keniry, James M. Ford, et al.. (1990). Biochemical correlates of the antitumor and antimitochondrial properties of gossypol enantiomers.. Molecular Pharmacology. 37(6). 840–847. 99 indexed citations
15.
Hait, W N, et al.. (1990). Comparison of the efficacy of a phenothiazine and a bisquinaldinium calmodulin antagonist against multidrug-resistant P388 cell lines.. PubMed. 50(4). 1165–9. 14 indexed citations
16.
Hait, W N, Jürgen M. Stein, Alan J. Koletsky, Matthew W. Harding, & Robert E. Handschumacher. (1989). Activity of Cyclosporin A and a Non-Immunosuppressive Cyclosporin Against Multidrug Resistant Leukemic Cell Lines. PubMed. 1(1). 35–43. 23 indexed citations
17.
Hait, W N, et al.. (1988). Antitumor and Toxic Effects of Combination Chemotherapy With Bleomycin and a Phenothiazine Anticalmodulin Agent1. JNCI Journal of the National Cancer Institute. 80(4). 246–250. 20 indexed citations
18.
Hait, W N, Jürgen M. Stein, Alan J. Koletsky, et al.. (1987). Modulation of doxorubicin dox resistance by cyclosporin a csa and a non immunosuppressive homolog. 28. 298. 5 indexed citations
19.
Hait, W N, et al.. (1987). Pharmacological properties of fluphenazine-mustard, an irreversible calmodulin antagonist.. Molecular Pharmacology. 32(3). 404–409. 20 indexed citations
20.
Hait, W N, et al.. (1985). Inhibition of growth of leukemic cells by inhibitors of calmodulin: Phenothiazines and melittin. Cancer Chemotherapy and Pharmacology. 14(3). 202–5. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026